Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer. Edwards DM, Sankar K, Alseri A, Jiang R, et al. Int J Radiat Oncol Biol Phys 2023 Oct 2:S0360-3016(23)07971.

Read + Share

Amedeo Smart

Independent Medical Education

Edwards DM, Sankar K, Alseri A, Jiang R, et al. Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2023 Oct 2:S0360-3016(23)07971.
PMID: 37793573